Advances in prenatal care are giving expectant parents more insight than ever before. One of the most widely used tools is cell-free DNA (cfDNA) screening, also known as noninvasive prenatal testing (NIPT). This test helps identify the risk of certain genetic conditions early in pregnancy and allows families to make informed decisions about next steps in their care.
What is cfDNA Screening?
During pregnancy, fragments of DNA from the fetus circulate in the pregnant person’s blood. cfDNA screening analyzes these DNA fragments to assess whether the fetus is at higher or lower risk for specific chromosomal conditions.
The test can be performed as early as 10 weeks into pregnancy with just a simple blood draw.
Which Conditions Does cfDNA Screen For?
cfDNA screening focuses on conditions caused by extra or missing chromosomes (aneuploidy):
- Trisomy 21 (Down syndrome) – an extra copy of chromosome 21.
- Trisomy 18 (Edwards syndrome) – an extra copy of chromosome 18.
- Trisomy 13 (Patau syndrome) – an extra copy of chromosome 13.
- Sex chromosome differences (X and Y chromosomes) – if requested.
It’s important to note that cfDNA screening does not detect structural birth defects or most single-gene disorders.
Understanding the Results
Because cfDNA is a screening test, it does not provide a diagnosis. Instead, results indicate whether the risk is higher or lower compared with the general population:
- Positive result: Higher chance of a chromosomal condition.
- Negative result: Lower chance of a chromosomal condition.
If a screening result is positive, follow-up diagnostic testing such as chorionic villus sampling (CVS) or amniocentesis is needed for confirmation. These procedures can also identify other genetic disorders like cystic fibrosis or sickle cell disease.
Accuracy and Limitations
cfDNA is highly accurate for detecting Down syndrome and slightly less so for trisomy 13 and 18. However, false positives and false negatives can occur. Factors like maternal age, twin pregnancies, or conditions such as fibroids can also affect accuracy.
For example, a 40-year-old with a positive result for Down syndrome has about a 95% chance the result is accurate, while a 20-year-old with the same result has about a 55% chance.
What Happens Next?
If your cfDNA results show a higher risk, your healthcare provider may recommend:
- A detailed ultrasound examination
- Genetic counseling
- Diagnostic testing for confirmation
These next steps help clarify whether the fetus truly has the condition indicated by the screening.
Key Takeaways
- cfDNA screening is available starting at 10 weeks of pregnancy.
- It screens for trisomy 21, 18, 13, and sex chromosome differences.
- Results show risk level, not a diagnosis.
- Positive results should be followed up with diagnostic testing.
- cfDNA does not detect all genetic or structural conditions.
